Skip to main content
TOPMed

Parent/Study Descriptions and Statements

Notes: “phs” is a dbGaP study accession number prefix indicating a phenotype study. A study accession number is a unique, stable, and versioned identifier. 
For studies with no description in the table below, click on the phs number to see the summary provided on dbGaP. In the table, you may encounter phs links that redirect to a dbGaP error page. If so, this is because the TOPMed dbGaP study webpages do not go live until the study accession is released.

The table below provides the names of institutions providing ethics approval or oversight so TOPMed authors can respond to journals that require documentation for ethics review of studies involving human subjects. 

Is your study missing a description? Contact the TOPMed ACC.

Short Name Title TOPMed Accession # Description Ethics statement
JHU_AF The Johns Hopkins University School of Medicine Atrial Fibrillation Genetics Study phs001598
LTRC Lung Tissue Research Consortium phs001662 All LTRC participants provided written informed consent, and the study was approved by the Institutional Review Boards of the participating clinical centers.
Mayo_VTE Mayo Clinic Venous Thromboembolism Study phs001402 All Mayo_VTE participants provided informed consent and the study was approved by the Institutional Review Board of Mayo Clinic, Rochester, MN.
MDS Genomics of Myelodysplastic Syndromes phs002360
MESA Multi-Ethnic Study of Atherosclerosis phs001416 All MESA participants provided written informed consent, and the study was approved by the Institutional Review Boards at The Lundquist Institute (formerly Los Angeles BioMedical Research Institute) at Harbor-UCLA Medical Center, University of Washington, Wake Forest School of Medicine, Northwestern University, University of Minnesota, Columbia University, and Johns Hopkins University.
MESA AA_CAC Multi-Ethnic Study of Atherosclerosis Family cohort phs001416 All MESA/AA_CAC participants provided written informed consent, and the study was approved by the Institutional Review Boards at The Lundquist Institute (formerly Los Angeles BioMedical Research Institute) at Harbor-UCLA Medical Center, University of Washington, Wake Forest School of Medicine, Northwestern University, University of Minnesota, Columbia University, and Johns Hopkins University.
MGH_AF Massachusetts General Hospital Atrial Fibrillation Study phs001062
miRhythm Defining time-dependent genetic and transcriptomic responses to cardiac injury among patients with arrhythmias phs001434
MLOF My Life, Our Future: Genotyping for Progress in Hemophilia phs001515
MPP Malmo Preventative Project phs001544
Back to top